{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:26:21Z","timestamp":1787066781023,"version":"build-2736575974"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.1994","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T11:32:53Z","timestamp":1555673573000},"page":"e191994","source":"Crossref","is-referenced-by-count":49,"title":["Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation"],"prefix":"10.1001","volume":"2","author":[{"given":"Akihiko","family":"Nogami","sequence":"first","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Otani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokushima Red Cross Hospital, Komatsushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya Daini Red Cross Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"},{"name":"Department of Cardiology, Ibaraki Prefectural Central Hospital, Kasama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Nuruki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Goya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Origasa","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Clinical Epidemiology, University of Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Hirao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ABRIDGE-J (ABlation peRIoperative DabiGatran in use Envisioning in Japan) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"issue":"5","key":"zoi190095r1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.joa.2017.08.001","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.","volume":"33","author":"Calkins","year":"2017","journal-title":"J Arrhythm"},{"issue":"2","key":"zoi190095r2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCEP.111.964916","article-title":"Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis.","volume":"5","author":"Santangeli","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"23","key":"zoi190095r3","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.921320","article-title":"Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.","volume":"121","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"issue":"22","key":"zoi190095r4","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.107.727784","article-title":"Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.","volume":"116","author":"Wazni","year":"2007","journal-title":"Circulation"},{"issue":"25","key":"zoi190095r5","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","article-title":"Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.","volume":"129","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"issue":"17","key":"zoi190095r6","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation.","volume":"376","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"28","key":"zoi190095r7","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"zoi190095r8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jce.2016.27.issue-5","article-title":"Apixaban versus warfarin for the prevention of periprocedural cerebral thromboembolism in atrial fibrillation ablation: multicenter prospective randomized study.","volume":"27","author":"Kuwahara","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"zoi190095r9","first-page":"1368","article-title":"Safety and efficacy of uninterrupted periprocedural apixaban in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of 1,057 patients.","volume":"8","author":"Garg","year":"2016","journal-title":"J Atr Fibrillation"},{"key":"zoi190095r10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ijcard.2015.11.085","article-title":"Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: a metaanalysis of 1,362 patients.","volume":"203","author":"Garg","year":"2016","journal-title":"Int J Cardiol"},{"issue":"10","key":"zoi190095r11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/europace\/eut241","article-title":"Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature.","volume":"15","author":"Hohnloser","year":"2013","journal-title":"Europace"},{"issue":"5","key":"zoi190095r12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","article-title":"A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU Trial.","volume":"4","author":"Reynolds","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"32","key":"zoi190095r13","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.","volume":"39","author":"Kirchhof","year":"2018","journal-title":"Eur Heart J"},{"issue":"7","key":"zoi190095r14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force.","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"zoi190095r15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/europace\/euv132","article-title":"Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).","volume":"17","author":"Potpara","year":"2015","journal-title":"Europace"},{"issue":"8","key":"zoi190095r16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/europace\/euu007","article-title":"Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.","volume":"16","author":"Provid\u00eancia","year":"2014","journal-title":"Europace"},{"issue":"10","key":"zoi190095r17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/europace\/euu196","article-title":"Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.","volume":"16","author":"Winkle","year":"2014","journal-title":"Europace"},{"key":"zoi190095r18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijcard.2017.05.098","article-title":"First experience with edoxaban and atrial fibrillation ablation: insights from the ENGAGE AF-TIMI 48 trial.","volume":"244","author":"Steffel","year":"2017","journal-title":"Int J Cardiol"},{"issue":"3","key":"zoi190095r19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/CIRCEP.113.000320","article-title":"Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.","volume":"6","author":"Bassiouny","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"zoi190095r20","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/europace\/eut239","article-title":"Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.","volume":"15","author":"Bin Abdulhak","year":"2013","journal-title":"Europace"},{"issue":"20","key":"zoi190095r21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"zoi190095r25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy.","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"issue":"4","key":"zoi190095r26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"issue":"4","key":"zoi190095r27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jth.2005.3.issue-4","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgical patients.","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"zoi190095r28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation.","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi190095r29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1253\/circj.CJ-11-0191","article-title":"Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation: sub-analysis in Japanese population in RE-LY trial.","volume":"75","author":"Hori","year":"2011","journal-title":"Circ J"},{"issue":"23","key":"zoi190095r30","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation.","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi190095r31","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1161\/CIR.0000000000000477","article-title":"Management of patients on non\u2013vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American Heart Association.","volume":"135","author":"Raval","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"zoi190095r32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation.","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi190095r33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.hrthm.2012.12.011","article-title":"Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.","volume":"10","author":"Kim","year":"2013","journal-title":"Heart Rhythm"},{"issue":"13","key":"zoi190095r34","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","article-title":"Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.","volume":"59","author":"Lakkireddy","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"zoi190095r22","unstructured":"International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2016). Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R2__Step_4_2016_1109.pdf. Published November 9, 2016. Accessed March 6, 2019."},{"key":"zoi190095r23","unstructured":"Dabigatran package insert. http:\/\/www.bij-kusuri.jp\/leaflet\/attach\/pdf\/pxa_cap75_pi.pdf. Version 10, September 2017. Accessed August 9, 2018."},{"key":"zoi190095r24","unstructured":"Guidelines for indications and procedural techniques of catheter ablation (JCS 2012). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2012_okumura_h.pdf. Published 2012. Accessed August 9, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/4\/e191994\/17478461\/nogami_2019_oi_190095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T11:33:12Z","timestamp":1555673592000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2019.1994"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.1994","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]}}}